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Chapter 13.
The 15 kDa selenoprotein (Sepl5):
functional studies and a role in cancer etiology
Vadim N. Gladyshev
Department of Biochemistry, University of Nebraska, Lincoln, NE 68588, USA

Alan M. Diamond
Department of Human Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA

Dolph L. Hatfield
Section on the Molecular Biology of Selenium, Basic Research Laboratory, National Cancer
Institute, National Institutes of Health, Bethesda, MD 20892, USA

Summary: The 15 kDa selenoprotein (Sepl5) is one of several recently
identified selenoproteins. It contains a single selenocysteine residue in the
middle of a 162-amino acid open reading frame and has no detectable
homology to known proteins. The human Sepl5 gene spans 5 1 kb, has 5
exons and is located on chromosome 1 at position p3 1. The gene contains
two single nucleotide polymorphisms in the 3'-untranslated region (3'-UTR)
including one in the SECIS element, that are distributed differently between
Caucasians and African Americans. Sep 15 localizes to the endoplasmic
reticulum where it is tightly bound to UDP-glucose:glycoprotein
glucosyltransferase, a protein involved in the quality control of protein
folding. Sepl5 may be involved in the chemopreventive effect of dietary
selenium. This hypothesis is based on its differential expression in normal
and malignant tissues, the distribution and functional consequences of
natural polymorphisms within its gene, and the location of the Sepl 5 gene in
a region that is often altered in a variety of cancers.
Introduction
The number of selenoproteins identified thus far in vertebrates stands at 22
(see Chapter 9). The function of only a few of these proteins is known. Since
there is mounting evidence that at least some of the beneficial effects of
selenium on health, including its anticarcinogenic properties, are mediated
through selenoproteins, it is important to identify, characterize and determine
functions for as many selenoproteins as possible.

Selenium: Its molecular biology and role in human health
One of these proteins for which the function is not known is the 15 kDa
selenoprotein (Sepl5). Sepl5 was discovered about three years ago [ l ] when
it was purified from human T cells as a protein that was strongly radiolabeled
. Sepl5 cDNA sequence
when cells were grown in the presence of 7 5 ~ eThe
was deduced from the analysis of the EST database following sequencing of
several tryptic peptides obtained from the isolated selenoprotein. The new
open reading frame (ORF) contained an in-frame TGA codon (Figure 1) that
was predicted to encode selenocysteine (Sec). This conclusion was also
based on the presence of selenium in the protein and the fact that sequences
downstream of the in-frame TGA matched those predicted to encode tryptic
peptides in the isolated human T-cell Sepl5.
Analysis of human Sepl5 sequence using the EST database revealed that
this selenoprotein was expressed in a variety of human cell types and
identified its orthologs in other mammals. However, Sepl5 sequences had no
homology to known proteins making this protein a difficult target for
functional characterization. Recent biochemical and genetic studies [2-41
significantly advanced our understanding of the genetics and biochemistry of
Sep 15. These studies identified a binding partner for Sep 15 that implicated
this selenoprotein in the quality control of protein folding [4] and revealed
unexpected genetic factors that implicated Sepl5 in the dietary effect of
selenium in cancer prevention [2,3]. These studies are discussed in this
chapter.
The human Sepl5 gene
The complete sequence of the human Sepl5 gene has been recently
determined [2]. The gene spans a region of 5 1 kilobase pairs on chromosome
1 and consists of five exons and four introns (see Figure 1). The 5'untranslated region (5'-UTR) and the first 27 amino acid residues of a
putative signal peptide are included in the first exon. This peptide is not
present in Sepl5 isolated from human T cells [ l ] consistent with
posttranslational processing of the signal peptide. Such gene organization,
when the coding sequence for an amino terminal signal peptide is located in
a separate exon, has been observed for many other mammalian proteins. The
largest exon in the human Sepl5 gene is exon 5 which encodes C-terminal
sequences and also includes the 3'-UTR. The TGA codon that dictates Sec
incorporation into the resulting Sepl5 gene product is located in exon 3. The
site of initiation of transcription in the Sepl5 gene was determined by primer
extension and was found to lack a TATA box that is often found upstream of
RNA polymerase 11transcribed mammalian genes [2].
Two polymorphic sites, which are located in the 3'-UTR at positions 81 1
and 1125 in human cDNA, have been identified [I-31 and their locations in
the Sepl5 mRNA sequence are shown in Figure 1. In all DNA samples
examined to date, c8"is found associated with G"*' and T'" is associated
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with A~~~~suggesting the presence of two alleles. Interestingly, the
polymorphism at 1125 site is located in the apical loop of selenocysteine
insertion sequence (SECIS) element.
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Figure 1. Structural organization of the human 15 kDa selenoprotein gene. In the upper panel,
the exon-intron organization and relative sizes of exons and introns in the 5 1-kb human Sepl5
gene are shown. Horizontal lines correspond to introns and flanking regions, and the closed
squares to exons. In the lower panel, the organization of the human cDNA sequence obtained
by splicing of the Sepl5 gene is shown. The relative positions of the ATG initiation and the
TGA Sec codons, the TAA termination signal and the detected polymorphisms (81 1ClT and
1125GlA) are shown. The location of 1125GlA polymorphism in the apical loop of the SECIS
element is also indicated. The long horizontal line corresponds to the Sepl5 cDNA, and short
vertical lines correspond to exon-exon junctions. Numbers under junction sites correspond to
last nucleotides in preceding exons.

Amino acid sequences
Coding sequences within Sepl5 genes do not show detectable homology to
known proteins, nor do they have clear sequence motifs indicative of a
protein structure, cofactor composition or function (Figure 2). However,
Sepl5 genes were found in a wide variety of animals, including rats, mice,
zebrafish, fruit flies and nematodes (Figure 2) [1,2]. The position of Sec is
conserved in the Sepl5 vertebrate sequences, whereas in insects and
nematodes, Sec is replaced with Cys (Figure 2). Homology analyses also
indicate that vertebrate Sep 15 sequences are highly conserved. For example,
mature human and mouse Sepl5 differ by only three amino acid residues.
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Figure 2. Amino acid alignment of animal Sepl5 sequences. Residues identical in all
sequences are highlighted. U represents selenocysteine and is shown by a closed circle above
the sequence. Accession numbers for human and mouse Sepl5 sequences are AF05 1894 and
AF288740, respectively. Rat, bovine, Ciona intestinals (Ciona) and Penaeus vannamei
(shrimp) sequences were assembled from EST sequences. The Drosophila (Droso) Sepl5
sequence (accession number AE003523) was predicted by the Drosophila genome project.
This sequence appears to lack the first exon containing the N-terminal signal peptide. The C.
elegans (C.eleg) sequence (accession number AC024872) was predicted by the C. elegans
Genome Project and corrected to remove an additional intron.
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Pattern of expression
Following the initial EST analyses [I], expression of the Sepl5 gene was
examined in a number of human and mouse tissues by northern analysis and
immunoblot assays [2]. Highest levels of gene expression were observed in
prostate, liver, kidney, testes and brain, while lower levels were found in
lung, spleen and skeletal muscle.
The high expression of Sep15 in the prostate may be relevant to the recent
selenoprotein that migrated as -1 5observation of an abundant 75~e-labeled
16 kDa species on SDS PAGE gels [5]. In selenium deficiency, expression of
this protein was conserved, in contrast to that of another selenoprotein,
glutathione peroxidase 1. However, -1 5- 16 kDa protein has not been isolated
or its gene sequenced, making it difficult to compare this protein and Sepl5.
Mammalian cells contain a number of selenoproteins with predicted
molecular masses similar to that of mature Sepl5 [6]. Thus, the rat prostate
15 kDa selenoprotein detected by Behne and colleagues [5] is either Sepl5,
one of the selenoproteins identified recently by searching mammalian
genomes with various bioinformatics tools (Chapter 9), or a protein yet to be
characterized.
Association of Sepl5 and UGTR
Initial purification of Sepl5 from human T cells employed reversed-phase
chromatography as a final isolation step. Thus, SeplS was isolated in a
denatured state [I]. However, this protein migrated as -160 kDa species on
native gels. This observation suggested that SeplS is either composed of
multiple identical subunits or strongly binds another protein to form the 160
kDa complex. Taking advantage of the high expression level of Sepl5 in the
prostate, the protein was isolated in the native state from this organ by
combination of conventional chromatography and HPLC [4].
Native Sepl5 was found to occur in a complex with a 150 kDa protein.
The latter protein was then identified by methods of protein microchemistry
as UDP-g1ucose:glycoprotein glucosyltransferase (UGTR), an endoplasmic
reticulum-resident protein [7]. The function of UGTR is to glucosylate
misfolded proteins, thus retaining them in the endoplasmic reticulum until
they are correctly folded or transferring them to degradation pathways [8].
The Sepl5 gene was fused to a green florescent protein in order that the
expressed fusion protein could be tracked intracellularly. Consistent with its
association with UGTR, Sepl5 was localized to the endoplasmic reticulum
[4]. Furthermore, the N-terminal signal peptide, which was cleaved in the
mature protein, was found to be essential for its translocation. The Cterminal sequence of Sepl5 was not involved in retaining this protein in the
endoplasmic reticulum, and most likely, Sepl5 is retained in this
compartment by its association with UGTR. Sepl5 is the first known
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endoplasmic reticulum-resident selenoprotein and its complex with UGTR
suggests a role of selenium in the quality control of protein folding.

Influence of the A ~ ~ polymorphism
~ ~ / G on ~selenoprotein
~ ~ ~ expression
The fact that the A ' ~ ~ polymorphic
~ / G ~ ~site~occurs
~ in the apical loop of the
SECIS element suggested that it might differentially influence the level of
SeplS translation. This possibility prompted us to study the ability of
polymorphisms in the SeplS gene to support selenoprotein expression, as
well as to study the allelic frequencies within the human population and their
association with malignancy.
Initially, the ability of the nucleotide positions comprising the A ~ ~ ~ ~ /
polymorphism to influence selenoprotein expression was examined [2,3].
The SeplS 3'-UTR, encoding one or the other polymorphism, was attached
to the deiodinase 1 (Dl) gene in an expression vector. The levels of D l in the
chimeric constructs were compared to that of wild type D l [2]. The level
obtained with the
construct was approximately 75% of that observed
with wild type and the level with the GH2' construct was approximately 50%
of that of wild type. These data suggested that the identity of the base at
position 1125 ultimately may influence Sep 15 levels.
In contrast to the 1125 site, the base at position 81 1 did not influence the
level of Sepl5 expression. That is, a T ~ " / G " ~ ' construct yielded
approximately the same level of expression as c~"/G"~' and a c ~ ~ ~ / A
construct yielded approximately the same level of expression as T~"/A"~'
[2,31.
To further examine the consequences of the polymorphic nucleotide
positions with regard to their ability to influence the translation of mRNAs
containing an in-frame UGA codon, a construct was employed that permitted
us to test SECIS function by monitoring expression levels of full size and
truncated proteins. Again, the G form resulted in lower expression of the
reported construct. Thus, the data examining SECIS element efficiency as a
function of the two polymorphic positions in Sep15 clearly demonstrated that
the identity of the base at position 1125 influences the level of UGA
readthrough. However, in addition to influencing selenoprotein expression at
concentrations of selenium provided by 10% fetal bovine serum in cell
culture media, these polymorphisms differentially responded to additional
allelic
selenium supplementation of culture media [2,3]. Although the
form resulted in lower SECIS efficiency compared to the
form in the
absence of selenium supplementation, it was more responsive to increasing
selenium levels than the AHZ5form. The possibility that these properties may
have a role in cancer prevention is discussed below.

The 15 kDa selenoprotein (Sepl5)
Possible role of Sepl5 in cancer etiology
The finding that the SeplS gene occurs in humans as two allelic forms
allowed us to determine the frequencies at which these alleles are present in
the human population. Over 700 samples were analyzed by the PCR
amplification of the polymorphic region followed by diagnostic restriction
enzyme digestion [3]. This analysis revealed surprising differences in allele
frequencies between Caucasians and African Americans. In addition, this
study revealed differences in allele frequencies obtained from tumors of
breast or head and neck origin when compared to cancer-free individuals
among African Americans [3]. Furthermore, loss of heterozygosity (LOH) at
the Sep 15 gene locus was detected when DNA from circulating lymphocytes
of an African American patient with a supraglotis tumor was compared to the
DNA obtained from that tumor [3]. Development of cancer is often
accompanied by the LOH at the sites that encode protective genes that are
also called tumor suppressor genes. Thus, genetic changes at the Sepl5 locus
suggest that the loss of the Sepl5 gene (or possibly a gene in the vicinity of
the Sep15 gene) contributes to the development of certain cancers.
The human Sep 15 gene is located on chromosome 1 at position p3 1. This
region is commonly mutated or deleted in human cancers and the presence of
a tumor suppressor gene on lp3 1 has been suggested, but its identity has not
been established [9,10]. It is possible that the loss of one copy of Sep15 gene
may result in a decrease in the biosynthesis of this selenoprotein gene
product in malignant tissues relative to the corresponding normal tissues.
The observation that natural polymorphisms found in the 3'-UTR of the
Sep 15 gene may influence its translational efficiency in response to selenium
levels may also be relevant to the putative role of the protein in cancer. It is
possible that individuals representing different combinations of these two
haplotypes may express different amounts of Sepl5 and, in addition, they
may differentially respond to changes in dietary selenium (i.e., differentially
control translational levels of Sepl5 in response to changes in selenium
levels).
The fact that prostate in both humans and mice expresses high levels of
Sepl5 may also be relevant to the link between Sepl5 and cancer. Human
selenium supplementation trials revealed that dietary selenium can reduce the
incidence of prostate cancer [l 11 and it is likely that the greatest protection is
provided to those individuals with lower selenium intake. In addition,
epidemiological data have indicated a statistically significant inverse
correlation between selenium in the diet and prostate cancer [12]. However,
the mechanism of cancer prevention by selenium is poorly characterized [13]
and no selenoprotein has been implicated in such protection. The recent data
on Sepl5 raise the possibility that this protein may function in the prevention
of cancer and possibly serve as an agent by which selenium supplementation
exerts its chemopreventive effect.
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Although maximal protection against carcinogen-induced cancers in
rodents has been achieved by providing dietary selenium in amounts
exceeding levels that are necessary for maximal expression of GPxl and
GPx3 [13; and see Chapters 8, 14 and 231, these studies should not
necessarily be viewed as proof that selenoproteins are not involved in cancer
prevention. It is possible that distinct selenoproteins exhibit different
expression patterns at high concentrations of selenium or when individuals
are under environmental or genetic stress, such as those that are predisposed
to the risk of developing certain cancers. Consistent with this notion was the
observation that liver tumors of TGFalc-myc double transgenic mice (a
transgenic model of hepatocarcinoma) that were maintained on a seleniumsufficient diet had reduced levels of Sepl5 compared to adjacent hepatic
tissues [2]. In addition, Sepl5 was essentially undetectable in a mouse
prostate cancer cell line, while this protein was abundant in normal mouse
prostate [2]. If lower levels of the Sepl5 predispose an individual to
malignancy, then the observation of differences in SECIS element function
between the two naturally occurring alleles in the human population may
indicate a segment of the population who are either at greater risk of cancer
or whom might benefit from selenium supplementation. These observations,
together with the fact that alterations in the region on chromosome 1 where
the Sepl5 gene is located is often associated with cancer progression suggest
a possible role of Sep 15 in cancer etiology.
Concluding remarks
Sepl5 was discovered by virtue of the presence of selenium in the protein
and the relative abundance of Sepl5 compared to other selenoproteins.
However, characterization of its gene sequences failed to detect significant
homology to known proteins. Recent studies on the selenoprotein have
suggested insights into its function and a role in human health. Its
identification as a binding partner to the UGTR protein implicates Sepl5 in
the control of protein folding in the endoplasmic reticulum. In addition,
several biochemical and genetic observations have suggested that Sepl5 may
be involved in cancer development and may mediate, at least in part, the
chemoprotective effect of selenium. While these data hold great promise,
further studies are necessary to determine the relevance of Sepl5 to both
protein folding and cancer prevention.
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